Benzinga
06 Jun 2026, 20:04 UTC · 16w ago
Verdict
Headline leans bearish. We score ADCT −1.00 across three claims.
Score confirms the headline.
Leans bearish
From its wording — no explicit rating
−1.00strongly bearish
What the story claims
3 claims · scored −1 bearish … +1 bullish
ADC Therapeutics shares plummeted over 50% in pre-market trading following safety concerns in its Phase 3 LOTIS-5 trial.
More negative than 99% of claims this week
Julong Holding shares tumbled 36.65% after pricing an upsized $150 million public offering of common stock at a steep discount.
So whatSignificant equity dilution and a discounted offering price typically lead to immediate downward pressure on share value.
Continue reading
5 related stories
More negative than 94% of ticker scores this week
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More negative than 98% of claims this week
Nasdaq futures fell approximately 0.89% due to tech sector profit-taking and disappointing guidance from apparel and infrastructure companies.
More negative than 85% of claims this week
Which stocks this story touches
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Business Wire
6h ago
+22.3%
Price is moving against the score
$1.26 vs $1.03 close before publication (Jun 5) · not market-adjusted
ADCT chart →
